E Bork
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
Papers in
- Oncology 11
- Lung Cancer Research Studies 6
- Cancer Diagnosis and Treatment 3
-
- Neuroendocrine Tumor Research Advances 8
- Co-authors
- M Hansen (6 shared papers)P Dombernowsky (5 shared papers)Hansen Hh (2 shared papers)Heine H. Hansen (2 shared papers)Jens Benn Sørensen (2 shared papers)Torben Skovsgaard (2 shared papers)Lars Damstrup (2 shared papers)Jens J. Holst (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (2 papers)Recent results in cancer research (1 paper)Lung Cancer (1 paper)Clinical Endocrinology (1 paper)
- Partner nations
- DenmarkNetherlandsBelgium
In The Last Decade
E Bork
17 papers receiving 442 citations
Peers
Comparison fields: 5 of 66
- Otorhinolaryngology 52
- Oncology 279
- Pulmonary and Respiratory Medicine 227
- Epidemiology 120
- Neurology 34
Countries citing papers authored by E Bork
This map shows the geographic impact of E Bork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bork more than expected).
Fields of papers citing papers by E Bork
This network shows the impact of papers produced by E Bork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bork. The network helps show where E Bork may publish in the future.
Co-authors
The 25 scholars most cited alongside E Bork, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 67 | |
| 2 | Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. | 1985 | 67 |
| 3 | 1986 | 66 | |
| 4 | 1991 | 42 | |
| 5 | 1988 | 39 | |
| 6 | 1987 | 38 | |
| 7 | 1989 | 31 | |
| 8 | Phase II study of teniposide in small cell carcinoma of the lung. | 1984 | 24 |
| 9 | 1989 | 22 | |
| 10 | 1988 | 17 | |
| 11 | 1987 | 14 | |
| 12 | 1993 | 9 | |
| 13 | 1985 | 8 | |
| 14 | 1989 | 7 | |
| 15 | 1997 | 5 | |
| 16 | 2006 | 3 | |
| 17 | Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics. | 1986 | 1 |
About E Bork
E Bork is a scholar working on Oncology, Epidemiology, Molecular Biology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 17 papers that have together received 460 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (8 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (3 papers), Oral health in cancer treatment (3 papers), Cancer Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Otorhinolaryngology (52 citations), Oncology (279 citations), Pulmonary and Respiratory Medicine (227 citations), Epidemiology (120 citations) and Neurology (34 citations). E Bork has collaborated with scholars based in Denmark, Netherlands and Belgium. Frequent co-authors include M Hansen, P Dombernowsky, Hansen Hh, Heine H. Hansen, Jens Benn Sørensen, Torben Skovsgaard, Lars Damstrup, Jens J. Holst, H.H. Hansen and Anders G. Pedersen. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Recent results in cancer research, Lung Cancer and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.